WVE · Wave Life Sciences, Inc.
$5.29
+0.04 (+0.76%)
At close · Aug 21
Market Cap
$1.04B
Shares
197.05M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.29
Open$5.30
Day$5.27–5.48
52W close$5.05–21.31
Avg vol 30d2.8M
Short int16.4M · 8.3% float · 7.5d
Short vol27%
Last earningsJul 30, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 25, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−44%
below
Price vs 50-day avg
−9%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
2%
near low
Momentum
relative strength
1-month return
−9%
trailing
6-month return
−62%
trailing
YTD return
−69%
this year
Relative strength
−73%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
+2% holders QoQ · +50 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.32% of float · ▼ -2.7% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
240 holders — near 3-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
+149%
Y/Y
EPS growth
−73%
Y/Y
Free cash flow
$-188.2M
Balance sheet
$602.1M
net cash
Quant / Vol
risk profile
Volatility
169%
annualized · 1-yr
Max drawdown
−76%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−44%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
+2% holders QoQ · +50 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.32% of float · ▼ -2.7% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
240 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $5
Now $5 · 2%
Range high $21
vs 200-day avg -44%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WVE
this stock
Wave Life Sciences, Inc.
|
$1.04B | -68.9% | +149.4% | — | 8.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WVE | -2.2% | -9.0% | -61.8% | -4.0% | -68.9% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -0.9% | -12.6% | -73.4% | -6.5% | -81.2% |
Key facts
CIK
1631574
CUSIP
Y95308105
13F (30d)
222 filings
220 filers
Visit website
Investor relations